Skip to main content
. 2018 Jan 31;91(1084):20170795. doi: 10.1259/bjr.20170795

Figure 2.

Figure 2.

Absorbed dose profiles delivered by 186Re-HEDP (a) and and extrapolated for typical administered activities of 186Re-HEDP (b) 177Lu-EDTMP (c) 32P-Na3PO4 (d) 153Sm-EDTMP (e) 166Ho-DOTMP (f) and 89Sr-dichloride (g) obtained from the 379 bone lesions in the 22 patients. Note the three different ranges for the vertical axes: (a); (b-d); (e-g).